非传统组织学成分在尿路上皮癌中的新辅助化疗后病理结局
本研究多机构回顾206例新辅助化疗后根治性膀胱切除的尿路上皮癌患者,按术前TURBT有无非传统成分(UC-NCC)及数量分组,发现UC-NCC与完全病理缓解率和降期率更低相关,但成分数量与降期或完全缓解无相关性。
要点
- UC-NCC患者新辅助化疗后完全病理缓解率和降期率显著更低。
- UC-NCC成分数量与病理降期或完全缓解无显著相关性。
- 切缘阳性率在有无UC-NCC组间无显著差异。
核心结论
- UC-NCC的存在与新辅助化疗及根治性膀胱切除后不良病理结局相关。
研究设计与样本
- 多机构回顾性队列研究,纳入206例新辅助化疗后根治性膀胱切除且术前TURBT病理可用的尿路上皮癌患者。
主要发现
- UC-NCC组完全病理缓解率更低(p=0.021)。
- UC-NCC组病理降期率更低(p=0.027)。
- 切缘阳性率在有无UC-NCC组间无显著差异。
- UC-NCC数量与病理降期或完全缓解无相关性。
关键数值与推荐
- 完全病理缓解定义为ypT0/Tis/Ta ypN0。
- 病理降期定义为<ypT2 ypN0。
- 206例中92例为传统UC,73例有1个UC-NCC,30例有2个,11例有3个或以上。
临床怎么用
- 术前TURBT发现UC-NCC提示新辅助化疗后病理缓解可能性较低,应加强术后病理评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In urothelial carcinoma (UC), the presence of many form of divergent differentiation or histologic subtypes (henceforth collectively designated as UC with non-conventional components [UC-NCC]) negatively influences disease-specific clinical outcomes when compared to typical UC. Prior studies have suggested that UC-NCC may show lower rates of response to neoadjuvant chemotherapy (NAC), a factor that may partially explain their more aggressive course. However, data on post-NAC pathology outcomes in radical cystectomy (RC) are conflicting, and the influence of the number of UC-NCC on NAC response remains unknown. In this study, we evaluated the impact of UC-NCC on post-NAC RC outcomes, accounting for the number of UC-NCC components present within individual cases. METHODS: The pathology databases of the participating institutions were queried for post-NAC RCs. Those with pathology results available from the prior transurethral resection (TURBT) were selected for inclusion in the study. Cases were separated according to the presence or absence of UC-NCC in a pre-NAC TURBT showing muscle-invasive cancer. Those with UC-NCC were further stratified according to the number of UC-NCC present (1 versus 2 versus 3 or more). The following pathology outcomes were assessed on RCs: pathologic downstaging (<ypT2 ypN0), complete response (ypT0/Tis/Ta ypN0), histologic assessment of tumor regression, and margin status. RESULTS: This multi-institutional cohort consisted of 206 patients: 92 with conventional UC, 73 with 1 UC-NCC, 30 with 2 UC-NCC, and 11 with 3 or more UC-NCC. The presence of UC-NCC was associated with lower rates of complete pathologic response (p=0.021) and downstaging (p=0.027), without significant differences in the rate of positive surgical margins. There was no correlation between the number of UC-NCCs and pathologic downstaging or complete response. CONCLUSIONS: The presence of UC-NCC is associated with adverse pathologic outcomes following NAC and RC.
引用
- Youssef, Saeed, Baniak, et al. Non-Conventional Histologic Components in Urothelial Carcinoma: Post-Neoadjuvant Chemotherapy Pathologic Outcomes in a Multi-institutional Radical Cystectomy Cohort. Hum Pathol. 2026. PMID: 42956974. doi:10.1016/j.humpath.2026.106282
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。